Pear Therapeutics Inc Quick Ratio (PEAR) starting from the fourth quarter 2022 to fourth quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Pear Therapeutics Inc   (NASDAQ: PEAR)

Pear Therapeutics Inc 's Quick Ratio

PEAR's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2022, Quick Ratio fell to 1.2 below Pear Therapeutics Inc average.

Within Medical Equipment & Supplies industry 128 other companies have achieved higher Quick Ratio than Pear Therapeutics Inc in fourth quarter 2022. While Quick Ratio total ranking in the fourth quarter 2022 has deteriorated compared to the prior quarter from 1571 to 2014.

Explain Quick Ratio?
How much Cash & cash equivalents PEAR´s has?
What are PEAR´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PEAR Quick Ratio (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2		 (Mar 31 2022)
Q1		 (Dec 31 2021)
Q4
Y / Y Current Liabilities Change 4.83 % 1275.66 % 1738.49 % 11582.37 % 24.76 %
Y / Y Cash & cash equivalent Change -66.05 % 10750.41 % 7857.75 % 18242.17 % 40.29 %
Quick Ratio MRQ 1.2 1.74 2.28 2.96 3.7
PEAR's Total Ranking # 2014 # 1571 # 1418 # 1189 # 1027
Seq. Current Liabilities Change 2.67 % 2.53 % 1.27 % -1.67 % 1247.41 %
Seq. Cash & cash equivalent Change -29.12 % -21.93 % -22.05 % -21.29 % 22552.35 %



Quick Ratio fourth quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 129
Healthcare Sector # 816
Overall Market # 2014


Quick Ratio Statistics
High Average Low
3.7 1.81 0.22
(Dec 31 2021)   (Sep 30 2021)




Financial Statements
Pear Therapeutics Inc 's Current Liabilities $ 49 Millions Visit PEAR's Balance sheet
Pear Therapeutics Inc 's Cash & cash equivalent $ 59 Millions Visit PEAR's Balance sheet
Source of PEAR's Sales Visit PEAR's Sales by Geography


Cumulative Pear Therapeutics Inc 's Quick Ratio

PEAR's Quick Ratio for the trailling 12 Months

PEAR Quick Ratio

 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months		 (Dec 31 2021)
12 Months
Y / Y Current Liabilities TTM Growth 256.11 % 326.31 % 253.35 % 160.73 % 41.83 %
Y / Y Cash & cash equivalent TTM Growth 118.33 % 294.89 % 231.82 % 150.9 % 42.59 %
Quick Ratio TTM 2.03 2.66 2.92 3.15 3.31
Total Ranking TTM # 4619 # 4582 # 1167 # 1176 # 1231
Seq. Current Liabilities TTM Growth 1.21 % 31.01 % 44.59 % 85.76 % 21.15 %
Seq. Cash & cash equivalent TTM Growth -22.94 % 19.73 % 33.67 % 77.01 % 39.38 %

Quick ratio ranking by company, industry and sector >> Back to PEAR Financial Strength Comparisons >> Go to Compare PEAR Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q4 2022 to $49.44 millions, cumulative Quick Ratio decreased to 2.03 below the Pear Therapeutics Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 242 other companies have achieved higher Quick Ratio than Pear Therapeutics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2022 from 4582 to 4619.

Explain Quick Ratio?
How much Cash & cash equivalents PEAR´s has?
What are PEAR´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 243
Healthcare Sector # 1172
Within the Market # 4619


trailing twelve months Quick Ratio Statistics
High Average Low
3.31 2.81 2.03
(Dec 31 2021)   (Dec 31 2022)




Companies with similar Quick Ratio in the quarter ending Dec 31 2022, within Medical Equipment & Supplies Industry Quick RatioDec 31 2022 MRQ Cash & cash equivalentDec 31 2022 MRQ Current Liabilities
Lemaitre Vascular Inc   3.19 $ 82.691  Millions$ 25.941  Millions
Icecure Medical Ltd  3.18 $ 24.251  Millions$ 7.624  Millions
Edwards Lifesciences Corporation  3.13 $ 4,245.400  Millions$ 1,354.300  Millions
Edap Tms Sa  3.11 $ 70.712  Millions$ 22.750  Millions
Motus Gi Holdings Inc   2.93 $ 14.042  Millions$ 4.799  Millions
Irhythm Holdings Inc   2.92 $ 213.144  Millions$ 73.014  Millions
Logicmark Inc  2.89 $ 6.977  Millions$ 2.414  Millions
Nutriband Inc   2.77 $ 1.985  Millions$ 0.717  Millions
Inogen Inc   2.72 $ 187.014  Millions$ 68.648  Millions
Staar Surgical Co  2.69 $ 211.639  Millions$ 78.612  Millions
Treace Medical Concepts Inc   2.69 $ 81.252  Millions$ 30.245  Millions
Lucid Diagnostics Inc   2.67 $ 22.474  Millions$ 8.425  Millions
Milestone Scientific Inc   2.64 $ 8.715  Millions$ 3.300  Millions
Biotricity Inc   2.56 $ 12.473  Millions$ 4.867  Millions
Dariohealth Corp   2.56 $ 49.522  Millions$ 19.350  Millions
Stereotaxis Inc   2.55 $ 28.430  Millions$ 11.148  Millions
Electrocore Inc   2.54 $ 17.712  Millions$ 6.971  Millions
Koru Medical Systems Inc   2.50 $ 17.408  Millions$ 6.959  Millions
Intuitive Surgical Inc   2.46 $ 4,117.900  Millions$ 1,674.700  Millions
Icad Inc  2.44 $ 21.313  Millions$ 8.735  Millions
Glucotrack Inc   2.28 $ 2.312  Millions$ 1.013  Millions
Prosomnus Inc   2.24 $ 15.916  Millions$ 7.090  Millions
Axogen inc   2.17 $ 48.789  Millions$ 22.443  Millions
Neuronetics Inc   2.17 $ 70.340  Millions$ 32.375  Millions
Heartbeam Inc   2.16 $ 3.594  Millions$ 1.665  Millions
Catheter Precision Inc   2.09 $ 15.859  Millions$ 7.576  Millions
Mimedx Group Inc   2.09 $ 65.950  Millions$ 31.537  Millions
Sharps Technology Inc   2.08 $ 4.171  Millions$ 2.007  Millions
Atricure Inc   2.07 $ 121.113  Millions$ 58.392  Millions
Cytosorbents Corporation  1.94 $ 22.145  Millions$ 11.410  Millions

Date modified: 2026-09-08T15:22:10+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.